Lotke Tambuyzer
Beerse, VLG 2340, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia.
Journal: Vaccines
Published: June 12, 2025
Evolution of inflammation and immunity in a dengue virus 1 human infection model.
Journal: Science translational medicine
Published: October 26, 2022
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Journal: Nature
Published: June 29, 2022
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age.
Journal: AIDS (London, England)
Published: April 08, 2021
Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.
Journal: SAGE open medicine
Published: June 17, 2016
Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2'-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3'-5'-Cyclic Phosphate Ester Prodrug of 2'-Deoxy-2'-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition.
Journal: Journal of medicinal chemistry
Published: May 17, 2016
Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study.
Journal: Antiviral therapy
Published: November 01, 2015
Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults.
Journal: Journal of the International AIDS Society
Published: November 15, 2014
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
Journal: HIV medicine
Published: October 23, 2014
Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients.
Journal: AIDS research and treatment
Published: September 11, 2014
Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 07, 2014
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies.
Journal: Journal of hepatology
Published: August 14, 2014
Last Updated: 09/26/2026